The company
Standard BioTools Inc.
LAB · Nasdaq
LAB stood above a rising 150-day average in 12 of the last 52 weekly readings, and has been out of that trend for the last 37 weeks. It is 25.8% below that average now. Life Science Tools & Research Services: 52% of its 79 stocks in an uptrend (+4 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 37
- Industry in uptrend
- 52% +4 in 4 wk
- Insider buys, 12 months
- $14.4M
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 137 (-8)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 12 of 52 weeks.
Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Casdin Capital, LLCunchanged · filed 14 Aug 2026 | 88,783,856$73.0M | 00.0% |
| VIKING GLOBAL INVESTORS LPunchanged · filed 14 Aug 2026 | 58,651,170$48.3M | 00.0% |
| MAK CAPITAL ONE LLCadded · filed 14 Aug 2026 | 28,813,904$23.7M | +2,641,278+10.1% |
| Long Focus Capital Management, LLCadded · filed 14 Aug 2026 | 23,500,000$19.3M | +7,484,279+46.7% |
| VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026 | 12,252,998$10.1M | -563,072−4.4% |
| BlackRock, Inc.reduced · filed 7 Aug 2026 | 8,254,443$6.8M | -16,501,641−66.7% |
| Hollow Brook Wealth Management LLCreduced · filed 14 Aug 2026 | 5,503,381$4.5M | -150,000−2.7% |
| NEUBERGER BERMAN GROUP LLCadded · filed 13 Aug 2026 | 4,958,620$4.0M | +301,035+6.5% |
| Qube Research & Technologies Ltdadded · filed 14 Aug 2026 | 4,820,463$4.0M | +4,116,056+584.3% |
| ROYCE & ASSOCIATES LPadded · filed 14 Aug 2026 | 4,525,333$3.7M | +1,519,804+50.6% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.